Current Rheumatology Reports

Papers
(The TQCC of Current Rheumatology Reports is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Breaking Barriers: Essential Reforms for a Competitive and Affordable Biosimilars Market134
Decoding the Intricacies of Statin-Associated Muscle Symptoms40
Future of Low-Dose Computed Tomography and Dual-Energy Computed Tomography in Axial Spondyloarthritis39
Expert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response38
The Microbiome in Osteoarthritis: a Narrative Review of Recent Human and Animal Model Literature38
Ectopic Nociceptor Sprouting as a Key Peripheral Driver of Pain in Rheumatoid Arthritis34
Interstitial Pneumonia with Autoimmune Features: What the Rheumatologist Needs to Know33
Ultrasound Beyond Joints: A Review of Extra-Articular Applications in Rheumatology32
Deep Insight into the Role of MIF in Spondyloarthritis32
AA Amyloidosis: A Contemporary View32
Current perspective on infections and mitigation strategies in primary systemic vasculitis30
Treatment of Persons with Rheumatoid Arthritis with a History of Cancer27
Identification of Common Pathogenic Pathways Involved in Hemochromatosis Arthritis and Calcium Pyrophosphate Deposition Disease: a Review27
Cardiac Manifestations in Behçet’s Syndrome24
Considerations for Pharmacologic Management of Rheumatoid Arthritis in the COVID-19 Era: a Narrative Review24
How to Monitor Disease Activity of Axial Spondyloarthritis in Clinical Practice24
Synovial Tissue Insights into Heterogeneity of Rheumatoid Arthritis23
Broadening the Scope of Resilience in Chronic Pain: Methods, Social Context, and Development23
Exploring the Complex Relationship Between Microbiota and Systemic Lupus Erythematosus22
Unveiling the Potential of Probiotics in Osteoarthritis Management21
Classification Criteria for ANCA Associated Vasculitis – Ready for Prime Time?20
MRI in the Diagnosis and Treatment Response Assessment of Chronic Nonbacterial Osteomyelitis in Children and Adolescents20
Flares in Lupus Nephritis: Risk Factors and Strategies for Their Prevention20
Immune Checkpoint Inhibitor Associated Rheumatoid Arthritis19
Spectrum of Large- and Medium-Vessel Vasculitis in Adults: Neoplastic, Infectious, Drug-Induced, Autoinflammatory, and Primary Immunodeficiency Diseases19
Is There Still a Role of Plasma Exchange in the Current Management of ANCA-Associated Vasculitides?19
An Update on the Diagnosis and Management of Calcium Crystal Disease19
Narrative Review: Peripheral Arterial Disease in Patients with Hyperuricemia and Gout18
Epidemiology of Antiphospholipid Syndrome in the General Population17
Calcium Pyrophosphate Crystal Deposition: Insights to Risks Factors and Associated Conditions16
Newer Autoantibodies and Laboratory Assessments in Myositis16
Spondyloarthritis Research and Treatment Network (SPARTAN) Clinical and Imaging Year in Review 202416
Digital Approaches for Myositis15
Anti- Melanoma Differentiation-Associated Gene 5 Antibody Positive Dermatomyositis: Recent Progress in Pathophysiology and Treatment15
Air Pollution and Rheumatoid Arthritis Risk and Progression: Implications for the Mucosal Origins Hypothesis and Climate Change for RA Pathogenesis15
Advances in Drug Research Targeting Neutrophils for the Treatment of Rheumatoid Arthritis15
What can Animal Models tell us About T Cells in Spondyloarthritis Pathogenesis?15
Digital Health and Self-Management in Idiopathic Inflammatory Myopathies: A Missed Opportunity?14
Keratinocytes – Amplifiers of Immune Responses in Systemic Lupus Erythematosus13
Intravenous Immunoglobulin in Idiopathic Inflammatory Myopathies: a Practical Guide for Clinical Use13
Calcium Pyrophosphate Crystal Formation and Deposition: Where Do we Stand and What Does the Future hold?13
What to Know About Biopsy Sampling and Pathology in Vasculitis?13
0.13572812080383